MedTrace Logo

Gastric Bypass After Previous Anti-reflux Surgery

NCT01041105 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2010-01-01

No results posted yet for this study

Summary

The goal of this study is to describe the clinical presentation, indications, and operative treatment as well as assess the morbidity, mortality, and overall performance of revisional Roux-en-Y gastric bypass (RYGB) after either failed or functional antireflux surgery "ARS" in obese patients. With such information, we hope to determine which features might assist us in advancing our knowledge about Gastro-Esophageal Reflux Disease "GERD", the best option for primary ARS, and mechanisms of failure in the obese population as well as in identifying predictors of outcome after revisional surgery in this population.

Conditions

  • Clinically Severe Obesity
  • Gastroesophageal Reflux Disease

Sponsors & Collaborators

Principal Investigators

  • Francisco M Tercero, MD · Research Associate, University of California San Francisco

  • Kelvin D Higa, MD · Professor of Surgery, University of California San Francisco

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-06-30
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01041105 on ClinicalTrials.gov